Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Category: Oncotarget

Oncotarget

Behind the Study: Targeting Stem Cells in Non-Small Cell Lung Cancer

March 25, 2022

Dr. Beatrice Aramini and Dr. Valentina Masciale from the University of Modena and Reggio Emilia details a 2020 research paper she co-authored and published by Oncotarget, entitled, “CD44+/EPCAM+ cells detect a… read more

Oncotarget

Behind the Study: Role of Cancer Associated Fibroblasts in Prostate Cancer

March 17, 2022

Dr. Nerymar Ortiz-Otero from the Meinig School of Biomedical Engineering, Cornell University, discusses a research paper she co-authored that was published by Oncotarget in Volume 11, Issue 12, entitled, “Cancer… read more

Oncotarget

Behind the Study: Weight Loss Strategies for Breast Cancer Survivors

March 3, 2022

Dr. Jennifer Sheng from Johns Hopkins School of Medicine details a 2021 editorial she co-authored with Dr. Vered Stearns that was published by Oncotarget, entitled, “Innovating and expanding weight loss strategies for breast… read more

Oncotarget

Behind the Study: CrkL Required for Donor T Cell Migration

February 18, 2022

Dr. Mobin Karimi from Upstate Medical University at Syracuse describes the research behind a 2020 paper he co-authored that was published by Oncotarget, entitled, “CrkL is required for donor T cell… read more

Oncotarget

Behind the Study: Oncogenic Transformation and Iron Chelation

February 7, 2022

Dr. Stephany Veuger and Dr. Gina Abdelaal from Northumbria University describe their 2021 review published by Oncotarget, entitled, “Reversing oncogenic transformation with iron chelation” Listen to an audio version of this post Behind… read more

Oncotarget

Behind the Study: Prognostic Markers in Adrenocortical Carcinoma

January 24, 2022

Dr. Monica Varun Tyagi from the Department of Surgery and Stanford Cancer Institute discusses the research paper she co-authored that was published by Oncotarget, entitled, “GATA3 and APOBEC3B are prognostic markers… read more

Oncotarget

Oncotarget’s Top 10 Most-Viewed Papers in 2021

January 21, 2022

Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021. — Listen to an audio version of this post #10: Metformin and berberine, two versatile drugs in treatment of common metabolic… read more

Oncotarget

Testimonial: Dr. Dean Felsher

January 20, 2022

Below is a transcript of the testimonial from Dr. Dean Felsher from Stanford University School of Medicine, Departments of Medicine and Pathology and member of Oncotarget’s Founding Editorial Board, about… read more

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis

Oncotarget

Behind the Study: Genomic, Neoantigen Evolution in Head, Neck Cancer

January 10, 2022

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis discuss their 2021 research published by Oncotarget, entitled, “Genomic and neoantigen evolution from primary tumor to first metastases in… read more

Oncotarget

Open-Access Oncotarget Shifts to Continuous Publishing

January 6, 2022

As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing. — Listen to an audio version of this announcement BUFFALO, NY, January 6, 2022 – Since its inception in… read more